申请人:Merck & Co., Inc.
公开号:US04431652A1
公开(公告)日:1984-02-14
4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives of the formula: ##STR1## where X and Y are independently selected from the group consisting of hydrogen, halogen, and C.sub.1-6 alkyl; provided that positions 2 and 6 of the substituted phenyl moiety may not be substituted by C.sub.3-6 alkyl; or a pharmaceutically acceptable salt thereof; useful in treating urinary tract, especially renal calcium oxalate lithiasis.
该公式的4-羟基-5-取代-3(2H)-异噻唑烷-1,1-二氧化物衍生物:##STR1##其中X和Y分别选自氢,卤素和C.sub.1-6烷基的群体;前提是取代苯基团的2和6位置不得被C.sub.3-6烷基取代;或其药学上可接受的盐;可用于治疗尿路,尤其是肾钙草酸盐结石。